Merck & Co. (MRK)

Total Assets

$129.80B

Quarterly · Period ending: · USD

MRK logo

MRK Total Assets

Latest reported$129.80B
MRK Quarterly Total Assets ($4.90B → $129.80B)
High-resolution chart · PNG

MRK total assets history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Merck & Co. Total Assets — Quarterly (USD)
Period endingTotal Assets (USD)
129,802,000,000
128,685,000,000
136,866,000,000
129,546,000,000
117,523,000,000
115,122,000,000
117,106,000,000
117,532,000,000
112,630,000,000
105,849,000,000
106,675,000,000
106,727,000,000
104,469,000,000
107,796,000,000
109,160,000,000
107,081,000,000
107,095,000,000
106,668,000,000
105,694,000,000
93,494,000,000
90,688,000,000
90,847,000,000
91,588,000,000
89,800,000,000
90,615,000,000
84,913,000,000
84,397,000,000
83,331,000,000
83,965,000,000
82,354,000,000
82,637,000,000
85,130,000,000
85,040,000,000
86,041,000,000
87,872,000,000
91,676,000,000
92,804,000,000
96,561,000,000
95,377,000,000
98,335,000,000
96,475,000,000
98,755,000,000
101,677,000,000
101,232,000,000
102,582,000,000
108,345,000,000
98,167,000,000
101,808,000,000
97,860,000,000
108,460,000,000
105,645,000,000
106,419,000,000
106,876,000,000
106,200,000,000
106,132,000,000
106,301,000,000
105,525,000,000
105,509,000,000
105,128,000,000
106,534,000,000
106,195,000,000
105,865,000,000
105,781,000,000
107,840,000,000
106,170,500,000
111,593,800,000
112,314,000,000
48,739,400,000
49,407,100,000
46,543,100,000
47,195,700,000
48,545,700,000
47,457,500,000
47,041,100,000
48,350,700,000
45,700,700,000
44,182,800,000
42,992,500,000
44,569,800,000
43,719,100,000
43,478,700,000
43,418,000,000
44,845,800,000
43,831,000,000
43,006,300,000
43,117,100,000
42,572,800,000
42,874,400,000
41,854,600,000
41,665,200,000
40,587,500,000
42,589,000,000
50,008,100,000
48,953,500,000
47,561,200,000
47,337,400,000
45,960,400,000
45,474,700,000
44,021,200,000
43,705,600,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.